Demand for prosthetic joints such as hip and knee replacements is on the rise, however with this there comes the increased risk of developing infections. This will result in a lower quality of life for patients alongside mounting pressure on the NHS and the economy due to repeated hospital visits and expensive, continuous treatments.
In this report, we have proposed a new method in order to reduce the chance of infection post-implantation, and our solution is focused on being biocompatible, sustainable and cost-effective.